TBI/fludarabine versus busulfan/fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allo-HCT. A study from the ALWP of the EBMT

dc.contributor.authorSwoboda, R.
dc.contributor.authorLabopin, M.
dc.contributor.authorGiebel, S.
dc.contributor.authorSchroeder, T.
dc.contributor.authorKroeger, N.
dc.contributor.authorArat, M.
dc.contributor.authorSavani, B.
dc.contributor.authorSpyridonidis, A.
dc.contributor.authorHamladji, R. M.
dc.contributor.authorPotter, V.
dc.contributor.authorDeconinck, E.
dc.contributor.authorYakoub-Agha, I.
dc.contributor.authorRambaldi, A.
dc.contributor.authorOzdogu, H.
dc.contributor.authorSanz, J.
dc.contributor.authorNagler, A.
dc.contributor.authorMohty, M.
dc.date.accessioned2023-01-04T11:29:37Z
dc.date.available2023-01-04T11:29:37Z
dc.date.issued2022
dc.identifier.endpage35en_US
dc.identifier.issn0268-3369en_US
dc.identifier.issueSupplement 1en_US
dc.identifier.startpage35en_US
dc.identifier.urihttp://hdl.handle.net/11727/8549
dc.identifier.volume57en_US
dc.identifier.wos000878153300055en_US
dc.language.isoengen_US
dc.relation.journalBONE MARROW TRANSPLANTATIONen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleTBI/fludarabine versus busulfan/fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allo-HCT. A study from the ALWP of the EBMTen_US
dc.typeconferenceObjecten_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Adsız doküman.pdf
Size:
12.75 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: